Conţinutul numărului revistei |
Articolul precedent |
Articolul urmator |
206 3 |
Ultima descărcare din IBN: 2024-04-16 20:35 |
SM ISO690:2012 ŢURCANU, Adela, PINEAU, Pascal, TCACIUC, Eugen, PITEL, Ecaterina, HASSAN, Abbas. Primary hepatocellular carcinoma and viral hepatitis in Republic of Moldova . In: Journal of Gastrointestinal and Liver Diseases, 2018, nr. S2(27), p. 77. ISSN 1841-8724. |
EXPORT metadate: Google Scholar Crossref CERIF DataCite Dublin Core |
Journal of Gastrointestinal and Liver Diseases | ||||||
Numărul S2(27) / 2018 / ISSN 1841-8724 /ISSNe 1842-1121 | ||||||
|
||||||
Pag. 77-77 | ||||||
|
||||||
Descarcă PDF | ||||||
Rezumat | ||||||
Background: Republic of Moldova is, actually, both for men (12.5/105) and women (5.4/105), the European country with the highest primary liver cancer (PLC) incidence. (WHO, 2017). The local forms taken by PLC as well as its mode of presentation in Moldova have been only barely, if ever described in the medical literature. Aim: to estimate the tolls taken by the different risk factors of PLC in Moldova to provide National and European Public Health decision makers more insights in the worrying local situation. Material and Methods We conducted a retrospective study on 148 PLC cases diagnosed in the tertiary healthcare Institution from Chisinau, to determine the tolls attributable to the different risk factors prevalent in Moldova and the different tumor features that result from their activities. A series of 148 primary liver tumors was analyzed for demographic features, serological and biochemical data, and clinical - survival presentation. Results: The mean age of patients was 59±10 years (range: 19-66) with a M : F sex ratio of 1: 9. Viral hepatitis as a risc factors in HCC was: HCV (55.3%), HBV (36.1%), and HDV (18.5%). HCV infected patients were characterized by a slightly higher BMI (24.0±4.0 vs 22.5±3.5, P=0.041) and smaller tumors (54.6±32.8 vs 65.9±38.4mm, P=0.0766, ns) than other patients. Patients infected from southern Moldova were overrepresented among HBV HBsAg carriers (27.7% vs 10.2%, OR=3.17, 95%CI: 1.17-9.05, P=0.012). They patients were more often tattooed than the others (22.2 vs 6.1%, OR=4.3, 95%CI: 1.1-20.2, P=0.019). Co-infected patients [HBsAg(+)/anti-HCV(+)] were likewise more often coming from the Southern region (38.8 vs 14.1%, OR=3.80, 95%CI: 1.09-12.63, P=0.0174) and more often tattooed (31.2 vs 9.5%, P=0.0308) and/or intravenous drug users (23.5 vs 7.3%, P=0.0022) than others. Patients infected with Delta were 6 years younger than other (54.0±8.3 vs 60.5±10.1 years, P=0.0041) and affected with larger tumors (75.7±9.6 vs 56.0±3.2, 0.0184). As expected, CLIP score was slightly higher in HDV than in other patients. Conclusions: A pro-active policy of screening for persistent liver infection targeting population at risk of HCC (>50 years) and coupled with administration of antivirals in positive cases should be rapidly conducted in Moldova to reduce incidence or primary liver cancer. |
||||||
|